A Phase l clinical study evaluating the distribution and dynamic behavior of Nuclide labeled TH-SC01 cells in vivo in patients with Radiation proctitis
Signed informed consent
Good physical condition (WHO performance status score 0-1).
Patient received radiotherapy after being pathologically diagnosed with pelvic malignant tumors
Patient diagnosed with chronic radiation proctitis after undergoing colonoscopy more than 6 months after the completion of radiotherapy and did not respond to conventional treatment.
Patients with severe, progressive and uncontrollable diseases of the liver, blood, gastrointestinal tract, endocrine system, lungs, heart, nervous system, mental system or brain.
Patients with allergic constitution or severe systemic autoimmune diseases.
Patients with active massive gastrointestinal bleeding or acute intestinal obstruction during the screening period.
Pregnant or lactating women.